伊士曼化学公司（NYSE：EMN）today announced that it has entered into a definitive agreement to acquire Genovique Specialties Corporation, a leading global producer of specialty plasticizers, benzoic acid, and sodium benzoate. The acquisition will establish Eastman as a global leader in non-phthalate plasticizers for both general purpose and specialty markets. Terms of the transaction were not disclosed.
预计该交易有望获得伊士曼2010年全年每股收益。交易完成后，包括其在马里兰州切斯特敦的制造业务，包括其在中国武汉的合资企业，将成为Eastman绩效化学品和中间人（PCI）部分的一部分。
"Eastman continues to execute its strategy to grow the company through strategic uses of cash. This acquisition aligns with Eastman's strategic goals of investing in differentiated, sustainably-advantaged products and diversifying into emerging geographies," said Jim Rogers, president and CEO. "We look forward to delivering on the benefits this transaction creates for our customers and stockholders alike."
在全球范围内约90亿美元的增塑剂市场中，监管变化和转移消费者的偏好推动了对非邻苯二甲酸盐解决方案的需求不断上升。预计对非邻苯二甲酸盐替代方案的需求不断增长，在未来北美和欧洲的未来五年中，非邻苯二甲酸盐增塑剂的体积将增加7％。针对发达国家出口的产品的新兴市场的需求也在增加，该法规有利于使用非邻苯二甲酸盐增塑剂。
伊士曼is currently a supplier in North America and Europe of general purpose non-phthalate plasticizers for flexible PVC applications. With 2009 revenues of approximately $135 million, Genovique Specialties is a global producer of specialty non-phthalate plasticizers based on benzoic acid for water based adhesives, a new product line for Eastman. Genovique's production and distribution capabilities and customer relationships in Europe and Asia also enhance Eastman's diversification in regions targeted for growth.
“ Genovique专业是一种战略性的补充，可以使我们发展吸引人的增塑剂产品线，”性能聚合物和化学中间体执行副总裁Ron Lindsay说。“借助Genovique，我们将能够更好地满足客户对非邻国的需求，同时在增塑剂市场的高增长，高利润市场中扩大了伊士曼的存在。”
The acquisition is expected to be completed after receipt of required regulatory approvals and satisfaction of other customary closing conditions. It is expected to be funded with available cash. The Valence Group acted as exclusive financial advisor to Eastman on this transaction.